Active Biotech AB (publ) (ACTI.ST)

SEK 0.11

(-7.32%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - 6.72 Million 8.42 Million 20.05 Million
Cost of Revenue 1.67 Million 1.49 Million 1.28 Million - - -
Gross Profit -1.67 Million -1.49 Million -1.28 Million 6.72 Million 8.42 Million 20.05 Million
Operating Expenses 44.8 Million 57.88 Million 49.78 Million 39.03 Million 40.71 Million 49.89 Million
Selling, General and Administrative Expenses 13.94 Million 15.06 Million 15.24 Million 13.48 Million 12.23 Million 10.57 Million
Research and Development Expenses 32.54 Million 42.82 Million 34.53 Million 25.54 Million 28.47 Million 39.31 Million
Other Expenses - - - - 4.88 Million -
Cost and Expenses 46.48 Million 57.88 Million 49.78 Million 39.03 Million 40.71 Million 49.89 Million
Operating Income -46.48 Million -57.88 Million -49.78 Million -32.3 Million -32.28 Million -29.84 Million
Interest Expense - 206 Thousand 26 Thousand 87 Thousand 1.93 Million 6.97 Million
Income Tax Expense - 319 Thousand 58 Thousand -128 Thousand 1.93 Million -67 Thousand
Earnings before Tax -45.8 Million -58.37 Million -49.82 Million -32.24 Million -34.13 Million -36.87 Million
Net Income -45.8 Million -58.69 Million -49.88 Million -32.11 Million -36.06 Million -36.87 Million
Earnings Per Share Basic -0.17 -0.23 -0.20 -0.19 -0.18 -0.22
Earnings Per Share Diluted -0.17 -0.23 -0.20 -0.19 -0.18 -0.22
Weighted Average Shares Outstanding 269.41 Million 260.03 Million 245.65 Million 168.37 Million 200.56 Million 170.6 Million
Weighted Average Shares Outstanding (Diluted) 271.52 Million 260.03 Million 245.65 Million 168.37 Million 200.56 Million 170.6 Million
Gross Margin - - - 1.00 1.00 1.00
EBIT Margin - - - -4.62 -3.72 -1.46
Profit Margin - - - -4.78 -4.28 -1.84
EBITDA -43.88 Million -56.67 Million -48.51 Million -30.83 Million -31.32 Million -29.46 Million
Earnings Before Tax Margin - - - -4.80 -3.83 -1.49

Income Statement Charts